Stock Analysis
Alignment Healthcare, Inc. (ALHC) Stock Analysis
Alignment Healthcare, Inc. (ALHC) stock analysis covering valuation, fundamentals, technical indicators, risk, AIQ Momentum, analyst catalysts, dividends, and the current AIQ Score.
Alignment Healthcare, Inc. (ALHC) currently has an AIQ Score of 42/100, indicating a neutral setup. Sentiment is the strongest factor at 53/100. Quality is the weakest current factor at 37/100. Technical, fundamental, catalyst, dividend, and risk evidence should be read together at the latest market-close snapshot.
ALHC at a Glance
Crawlable current metrics from the latest market-close stock snapshot.
| Metric | Current |
|---|---|
| Price | $13.54 |
| AIQ Score | 42/100 |
| Overall View | Neutral |
| Technical Analysis Consensus | Sell |
| Market Cap | $2.82B |
| P/E Ratio | 71.53 |
| Forward P/E | — |
| EPS | $0.18 |
| Revenue TTM | $1.34B |
| Dividend Yield | 0.00% |
| Beta | 1.13 |
| Volume | 5.1M |
| 52-week range | $12.70-$25.12 |
| RSI 14 | 51.5 |
| 50-Day SMA | $17.22 |
| 200-Day SMA | $18.88 |
| Analyst Price Target | $19.60 |
| Next Earnings | Oct 29, 2026 |
ALHC
OverviewALHC Stock Analysis Summary
Alignment Healthcare, Inc. (ALHC) currently has an AIQ Score of 42/100, indicating a neutral setup. Sentiment is the strongest factor at 53/100. Quality is the weakest current factor at 37/100. Technical, fundamental, catalyst, dividend, and risk evidence should be read together at the latest market-close snapshot.
In a neutral regime, ALHC has AIQ Score of 42/100 with Sentiment base of 53/100 and fading Quality at 37/100. Wait for component alignment before adding exposure.
Healthcare · -0.04% stock move · ALHC classified in Medical - Healthcare Plans.
Current Evidence
AlgovestIQ Evidence Summary
Current consensus, supporting evidence, recent changes, and what would strengthen or weaken the view.
Is ALHC Bullish or Bearish Right Now?
ALHC currently has a neutral overall setup. Sentiment is the strongest factor at 53/100, while Quality is weakest at 37/100. The current evidence suggests a mixed rather than strongly bullish or bearish setup.
- - Analyst target implies +44.76% upside from the latest quote.
- - Value is the current constraint at 42/100.
- - Momentum is weak at 44/100.
- - Price is -28.28% below its 200-day SMA.
- - Technical consensus has more sell votes than buy votes (27 vs 9).
Current Consensus
ALHC's Technical Analysis Consensus is currently Sell, with 9 buy, 9 neutral, and 27 sell votes. ALHC's 14-day RSI is 51.5, which places the stock in a neutral momentum range. ALHC's beta is 1.13, indicating market sensitivity broadly in line with the market.
What Changed in ALHC?
Recent score-change history is not available in the current snapshot. These are the latest market-close scores instead.
What Would Change the ALHC Outlook?
The current neutral outlook could improve if AIQ moves above 70, momentum recovers, earnings revisions strengthen, and price confirms a stronger trend above the 50-day and 200-day moving averages. It would weaken if AIQ falls below 40, price loses long-term moving-average support, analyst expectations deteriorate, or risk evidence worsens.
AIQ > 70, RSI above 55, price above SMA-50/SMA-200, and positive catalyst or estimate-revision evidence.
AIQ below 40, RSI below 45, loss of SMA-200, negative revisions, or rising volatility and drawdown risk.
ALHC Decision Framework
Public evidence layers, setup checks, and risk context for Alignment Healthcare, Inc..
Alignment Healthcare, Inc. (ALHC) Stock Analysis
Alignment Healthcare, Inc. has an AIQ Score of 42/100 in a Neutral regime. Sentiment is strongest at 53/100. Beta is 1.13, above market sensitivity. Review the supporting stock factors together before drawing a conclusion from any single score.
| Evidence Layer | Public Evidence |
|---|---|
| Regime Context | ALHC is in a Neutral AIQ regime with score 42/100. |
| Signal Conflict | The primary conflict is that sentiment leads at 53/100 while quality lags at 37/100. |
| Factor Evidence | Momentum 44/100 · Value 42/100 · Quality 37/100 · Risk 51/100 · Sentiment 53/100 |
| Persistence | Current snapshot evidence is shown; historical persistence remains in AIQ Pro. |
Current Setup Checklist
Sentiment is the strongest factor at 53/100.
Momentum is 44/100 and RSI (14) is 51.5.
ALHC is in a Neutral regime at 42/100.
Risk factor is 51/100 with beta 1.13 and annual volatility 61.84%.
Current conflict: sentiment leads at 53/100 while quality lags at 37/100.
ALHC Research Cluster
Ticker-specific paths for valuation, technical analysis, catalysts, dividends, financials, risk, and news.
ALHC Fundamentals
ALHC valuation, profitability, growth, margins, balance-sheet strength, and free cash flow.
ALHC Technical Analysis
ALHC technical setup based on RSI, MACD, moving averages, AIQ Momentum, volume, trend, volatility, and pivots.
ALHC Stock Catalysts
Track ALHC earnings, analyst ratings, price targets, estimate revisions, stock news, and upcoming events.
ALHC Dividend Analysis
ALHC dividend yield, annual dividend, payout ratio, payment history, and income reliability context.
ALHC Financial Data
ALHC revenue, earnings, income statement, balance sheet, cash flow, valuation ratios, and stock metrics.
ALHC Risk Analysis
ALHC volatility, beta, drawdown, Sharpe ratio, VaR, and downside resilience.
ALHC Stock News
ALHC stock news, market tone, recent headlines, and catalyst context.
ALHC vs Healthcare Services / Managed Care Peers
Current peer cohort: ALHC · BKD · CAH · CI · CLOV. Compare AIQ, factor scores, Sharpe ratio and 1-year volatility in one indexable view.
| Peer | AIQ | Value | Momentum | Risk | Sharpe | 1Y Volatility | Compare |
|---|---|---|---|---|---|---|---|
| ALHC Current stock | 42/100 | 42/100 | 44/100 | 51/100 | -0.05 | 61.84% | Current |
| BKD Brookdale Senior Living | 46/100 | 65/100 | 31/100 | 45/100 | 1.18 | 40.03% | ALHC vs BKD |
| CAH Cardinal Health | 55/100 | 57/100 | 79/100 | 56/100 | 1.71 | 29.80% | ALHC vs CAH |
| CI Cigna | 56/100 | 72/100 | 60/100 | 52/100 | -0.18 | 32.52% | ALHC vs CI |
| CLOV Clover Health | 41/100 | 42/100 | 47/100 | 37/100 | 0.96 | 67.06% | ALHC vs CLOV |
Peer cohort is resolved dynamically from the AlgovestIQ universe taxonomy and Compare relationship graph. Data as of Sep 4, 2026.
About the AIQ Score
Methodology for the current stock evidence.
The AlgovestIQ AIQ Score combines multiple dimensions of stock evidence, including momentum, valuation exposure, quality, risk resilience, sentiment context, and timing signals. It is a descriptive research score, not a guarantee of future performance or a personalized recommendation.
View AIQ methodologyFactor Diagnostics
A compact bridge from the AIQ score to the evidence tabs.
Open the return calculator with stock context while purchase price, shares, dates and fees remain user inputs.
AIQ Component Profile
Compare the five component scores on one consistent 0–100 scale.
Review earnings timing, revisions, news pressure, and prior event reactions in one place.
Open catalysts8 recent quarterly periods are available for review.
Checked Sep 5, 2026
Explore factor drivers, conflicts, persistence, and scenario sensitivity in the advanced workspace.
Fundamentals Verdict
Current snapshot fields are separate from reported-quarter statement tables.
Latest period Jun 30, 2026.
Market Confirmation
Technicals are summarized first, with the indicator library behind it.
Risk Alignment
Higher resilience is stronger; exposure metrics stay separate.
Continue Researching ALHC
Open the detailed evidence pages and workflows behind the stock overview read.
Premium Feature
Full AIQ Analysis
AIQ Intelligence
AIQ Pro for ALHC
Scenario Analysis
AIQ Scenario Builder
Portfolio Implication
Related Links
ALHC Stock FAQ
What is ALHC stock price today?
Alignment Healthcare, Inc.'s current stock price is $13.54. Use the live quote with AIQ Score, news, and risk context rather than treating price alone as a decision signal.
Is ALHC bullish or bearish right now?
ALHC's bullish or bearish read depends on the current AIQ Score, factor alignment, technical analysis consensus, valuation, risk, and catalyst evidence. A mixed setup should be treated differently from a broad confirmation across those signals.
What is ALHC's market cap?
ALHC's market cap is $2.82B based on the latest completed market-close snapshot from Sep 4, 2026. Use it with P/E ratio, revenue, and growth metrics to frame company size, valuation, and peer comparisons.
What is ALHC's current P/E ratio?
ALHC's current P/E ratio is 71.53 based on the latest completed market-close snapshot from Sep 4, 2026. Read it with revenue growth, margins, EPS, cash flow, and peer valuation rather than using P/E alone.
What is ALHC's RSI?
ALHC's 14-day RSI is 51.5 based on the latest completed market-close snapshot from Sep 4, 2026. RSI should be interpreted with MACD, moving averages, volume, volatility, and price trend.
Is ALHC above its 50-day and 200-day moving averages?
ALHC is -21.38% from its 50-day SMA and -28.28% from its 200-day SMA based on the latest completed market-close snapshot from Sep 4, 2026. Moving-average position should be read with momentum and broader AIQ evidence.
When is ALHC's next earnings date?
ALHC's next earnings date is currently listed as Oct 29, 2026. Earnings can reset revenue, EPS, price target, analyst rating, and catalyst expectations.
Does ALHC pay a dividend?
ALHC's dividend yield is 0.00% based on the latest completed market-close snapshot from Sep 4, 2026. Dividend yield should be read with payout ratio, free cash flow, growth, and balance-sheet strength.